David M Hwang Selected Research

Transplantation

12/2022	Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study.
11/2019	Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation.
1/2012	Nonspecific interstitial pneumonia: a study of 6 patients with progressive disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Hwang Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 02/2009
10	Lung Neoplasms (Lung Cancer) 04/2024 - 02/2009
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2009
7	Infections 01/2023 - 01/2005
5	Cystic Fibrosis (Mucoviscidosis) 01/2023 - 01/2012
4	Lung Injury 01/2023 - 01/2005
3	Fibrosis (Cirrhosis) 11/2023 - 09/2011
3	Inflammation (Inflammations) 11/2023 - 09/2011
3	Acute Lung Injury 01/2023 - 11/2019
3	Adenocarcinoma 04/2018 - 04/2004
2	Primary Graft Dysfunction 12/2022 - 01/2017
2	Mesothelioma 01/2020 - 03/2014
2	Reperfusion Injury 11/2019 - 05/2017
2	Bronchiolitis Obliterans Syndrome 01/2016 - 07/2011
2	Bronchiectasis 01/2013 - 01/2012
2	Bronchiolitis 09/2011 - 06/2009
1	Pathologic Processes 11/2023
1	Organizing Pneumonia 12/2022
1	Persistent Infection 12/2018
1	Pulmonary Edema 05/2017
1	Venous Thromboembolism 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Malignant Mesothelioma 03/2014
1	Idiopathic Pulmonary Fibrosis 01/2012
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2012
1	Virus Diseases (Viral Diseases) 01/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2012
1	Pneumonia (Pneumonitis) 10/2011
1	Respiratory Acidosis 10/2011
1	Hypothermia 10/2011
1	Necrosis 11/2010

Drug/Important Bio-Agent (IBA)

3	ErbB Receptors (EGF Receptor)IBA 03/2024 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
2	B7-H1 AntigenIBA 03/2024 - 01/2022
2	Interleukin-17 (Interleukin 17)IBA 11/2023 - 04/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 12/2018
2	Anaplastic Lymphoma KinaseIBA 11/2019 - 09/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 10/2011
2	16S Ribosomal RNAIBA 01/2012 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2012 - 10/2011
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Isoantigens (Alloantigen)IBA 11/2023
1	Claudin-5IBA 01/2023
1	beta-Aminoethyl Isothiourea (AET)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2022
1	serum P-component (CIt)IBA 01/2020
1	Inosine Monophosphate (IMP)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 05/2019
1	Aztreonam FDA LinkGeneric 05/2019
1	CefsulodinIBA 05/2019
1	Cefepime (Maxipime)FDA LinkGeneric 05/2019
1	LactamsIBA 05/2019
1	Ceftazidime (Fortum)FDA LinkGeneric 05/2019
1	Meropenem (Merrem)FDA LinkGeneric 05/2019
1	Piperacillin FDA LinkGeneric 05/2019
1	Sevoflurane (Ultane)FDA LinkGeneric 05/2017
1	Oxygen (Dioxygen)IBA 05/2017
1	Anesthetics (Anesthetic Agents)IBA 05/2017
1	InterleukinsIBA 04/2016
1	halofuginoneIBA 04/2016
1	PorphyrinsIBA 01/2016
1	Ribosomal RNAIBA 11/2015
1	matrigelIBA 05/2014
1	MetalsIBA 05/2014
1	ElastinIBA 12/2013
1	ElementsIBA 08/2013
1	CytokinesIBA 09/2012
1	Gefitinib (Iressa)FDA Link 05/2012
1	Tyrosine Kinase InhibitorsIBA 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Adenosine Triphosphate (ATP)IBA 01/2012
1	TitaniumIBA 01/2012
1	InflammasomesIBA 01/2012
1	Prostaglandins DIBA 10/2011
1	ProstaglandinsIBA 10/2011
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2011
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 10/2011
1	Phospholipases A2 (Phospholipase A2)IBA 10/2011
1	Secretory Phospholipases A2IBA 10/2011
1	Prostaglandins FIBA 10/2011
1	Matrix Metalloproteinases (MMPs)IBA 09/2011
1	Matrix Metalloproteinase InhibitorsIBA 09/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2011
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 11/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2010
1	Hematoxylin (Haematoxylon)IBA 11/2010

Therapy/Procedure

17	Therapeutics 04/2024 - 01/2005
11	Lung Transplantation 11/2023 - 06/2009
4	Drug Therapy (Chemotherapy) 12/2023 - 10/2014
3	Transplantation 12/2022 - 01/2012
3	Radiotherapy 01/2016 - 03/2014
2	Immunotherapy 04/2024 - 01/2017
1	Thoracoscopes 03/2017
1	Lasers (Laser) 01/2016
1	Photothermal Therapy 01/2016
1	Catheters 05/2014
1	Pneumonectomy (Lung Volume Reduction) 03/2014
1	Traction 01/2013
1	Intranasal Administration 01/2012